Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Sig

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

Vyvanse is the first oral ADHD stimulant with published data that demonstrated significant ADHD symptom improvement from 1.5 hours up to 13 hours after administration in children, from morning through homework and family time

And another medication is about to be released.